Trefoil Factor-1 (TFF1) Enhances Oncogenicity of Mammary Carcinoma Cells

Show simple item record

dc.contributor.author Amiry, Naeem en
dc.contributor.author Kong, XJ en
dc.contributor.author Muniraj, Nethaji en
dc.contributor.author Kannan, Nagarajan en
dc.contributor.author Grandison, Prudence en
dc.contributor.author Lin, J en
dc.contributor.author Yang, YL en
dc.contributor.author Vouyovitch, CM en
dc.contributor.author Borges, S en
dc.contributor.author Perry, Johanna en
dc.contributor.author Mertani, HC en
dc.contributor.author Zhu, T en
dc.contributor.author Liu, Dongxu en
dc.contributor.author Lobie, Peter en
dc.date.accessioned 2012-03-04T19:15:36Z en
dc.date.issued 2009-10 en
dc.identifier.citation Endocrinology 150(10):4473-4483 Oct 2009 en
dc.identifier.issn 0013-7227 en
dc.identifier.uri http://hdl.handle.net/2292/12658 en
dc.description.abstract The functional role of autocrine trefoil factor-1 (TFF1) in mammary carcinoma has not been previously elucidated. Herein, we demonstrate that forced expression of TFF1 in mammary carcinoma cells resulted in increased total cell number as a consequence of increased cell proliferation and survival. Forced expression of TFF1 enhanced anchorage-independent growth and promoted scattered cell morphology with increased cell migration and invasion. Moreover, forced expression of TFF1 increased tumor size in xenograft models. Conversely, RNA interference-mediated depletion of TFF1 in mammary carcinoma cells significantly reduced anchorage-independent growth and migration. Furthermore, neutralization of secreted TFF1 protein by polyclonal antibody decreased mammary carcinoma cell viability in vitro and resulted in regression of mammary carcinoma xenografts. We have therefore demonstrated that TFF1 possesses oncogenic functions in mammary carcinoma cells. Functional antagonism of TFF1 can therefore be considered as a novel therapeutic strategy for mammary carcinoma. (Endocrinology 150: 4473-4483, 2009) en
dc.language EN en
dc.publisher ENDOCRINE SOC en
dc.relation.ispartofseries Endocrinology en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://www.sherpa.ac.uk/romeo/issn/0013-7227/ en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.subject BREAST-CANCER-CELLS en
dc.subject HUMAN GROWTH-HORMONE en
dc.subject EPITHELIAL-MESENCHYMAL TRANSITION en
dc.subject PS2 PROTEIN en
dc.subject MESSENGER-RNA en
dc.subject E-CADHERIN en
dc.subject SPASMOLYTIC POLYPEPTIDE en
dc.subject MOLECULAR-MECHANISMS en
dc.subject SIGNALING PATHWAYS en
dc.subject MARKER GENES en
dc.title Trefoil Factor-1 (TFF1) Enhances Oncogenicity of Mammary Carcinoma Cells en
dc.type Journal Article en
dc.identifier.doi 10.1210/en.2009-0066 en
pubs.issue 10 en
pubs.begin-page 4473 en
pubs.volume 150 en
dc.rights.holder Copyright: ENDOCRINE SOC en
dc.identifier.pmid 19589871 en
pubs.author-url http://endo.endojournals.org/cgi/reprint/150/10/4473.pdf en
pubs.end-page 4483 en
pubs.publication-status Published en
dc.rights.accessrights http://purl.org/eprint/accessRights/RestrictedAccess en
pubs.subtype Article en
pubs.elements-id 87102 en
pubs.org-id Liggins Institute en
pubs.org-id Science en
pubs.org-id Science Research en
pubs.org-id Maurice Wilkins Centre (2010-2014) en
pubs.record-created-at-source-date 2010-09-01 en
pubs.dimensions-id 19589871 en


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics